Naratriptan as Short‐Term Prophylaxis of Menstrually Associated Migraine: A Randomized, Double‐Blind, Placebo‐Controlled Study

2001184 citationsJournal Article

Authors

Naratriptan, 1 mg, with tolerability similar to placebo, is an effective, short-term, prophylactic treatment for menstrually associated migraine.

Published in: Headache The Journal of Head and Face Pain

Volume 41, Issue 3, pp. 248-256

Field-Weighted Citation Impact: 5.75